KIT and mucositis: The findings indicate a possible role for FER amplification in driving the MAPK pathway, similar to KIT, another receptor tyrosine kinase that can be amplified or mutated in acral and mucosal melanoma, frequently also in conjunction with NF1 mutations [74].